Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 462.8297
- Book/Share 115.1473
- PB 3.1033
- Debt/Equity 0.7882
- CurrentRatio 0.8458
- ROIC 0.1255
- MktCap 310302025880.0
- FreeCF/Share 27.7703
- PFCF 12.279
- PE 14.6405
- Debt/Assets 0.2566
- DivYield 0.0248
- ROE 0.2226
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
Downgrade | UNH | Argus | Buy | Hold | -- | -- | April 21, 2025 |
Upgrade | UNH | HSBC Securities | Hold | Buy | -- | $595 | Jan. 10, 2025 |
News
UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.
Read More
UnitedHealth: Momentum Completes The Bullish Puzzle
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Positive
Trying to time the market with falling knives like UnitedHealth—which it was in the spring and summer—was extremely risky, so I chose to wait for momentum to return. Valuation metrics are attractive, with forward P/E and P/S ratios far below historical averages, making UNH a compelling value due to rock-solid fundamentals. Yesterday's reiteration of the EPS outlook by the management is crucial, as it underscores that the headwinds are temporary and their adverse effects are unlikely to persist for long.
Read More
At $350, Is UNH Stock Beaten Down And Ready To Bounce?
Published: September 10, 2025 by: Forbes
Sentiment: Positive
UnitedHealth Group (NYSE: UNH) jumped 8% on September 9, 2025, after the company said it is on track to meet its Medicare Advantage enrollment goals. The update eased investor concerns that the insurer could miss these critical targets amid ongoing operational challenges.
Read More
Tepper's 1,300% Leap Into UnitedHealth Stock Chaos Looked Crazy—Until It Didn't
Published: September 10, 2025 by: Benzinga
Sentiment: Positive
David Tepper's bold second-quarter buying spree in UnitedHealth Group Inc. UNH is already paying off. The billionaire hedge fund manager's Appaloosa Management increased its stake in the health insurance giant by a staggering 1,300% last quarter, turning a once-minor position into his fund's second-largest holding.
Read More
UNH "Remarkable Story:" Road to Recovery Ahead After Reaffirming FY25 EPS Guidance
Published: September 09, 2025 by: Schwab Network
Sentiment: Positive
UnitedHealth (UNH) remains more than 40% off all-time highs but is also about 50% off 52-week lows. George Tsilis says the company reaffirming EPS guidance gave investors a strong signal to take on shares.
Read More
Why UnitedHealth Group Stock Soared on Tuesday
Published: September 09, 2025 by: Investopedia
Sentiment: Positive
UnitedHealth Group (UNH) was the best-performing stock in the Dow Jones Industrial Average and the S&P 500 on Tuesday after the health care giant said the vast majority of its Medicare Advantage enrollees are likely to qualify for bonus payments from the federal government.
Read More
UnitedHealth makes investors like Warren Buffett happy by saying business is fine
Published: September 09, 2025 by: Market Watch
Sentiment: Positive
UnitedHealth's stock is surging, which is giving a nice boost to Warren Buffett's new 5-million-share stake in the health insurer.
Read More
Top Stock Movers Now: UnitedHealth Group, Fox, Freeport-McMoRan, and More
Published: September 09, 2025 by: Investopedia
Sentiment: Negative
The Dow, S&P 500, and Nasdaq were little changed at midday Tuesday following a report showing weaker-than-anticipated job growth. That raised speculation the Federal Reserve could move next week to cut interest rates more than previously thought.
Read More
UnitedHealth Group stock climbs on outlook confirmation
Published: September 09, 2025 by: Proactive Investors
Sentiment: Positive
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) shares moved up 4% to about $333 in late-morning trading on Tuesday after the health insurer reaffirmed its full-year 2025 financial guidance. The company confirmed its 2025 forecast of adjusted earnings of at least $16 per share with revenue in the range of $445.5 billion to $448 billion.
Read More
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?
Published: September 09, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.
Read More
UnitedHealth stock rising from the dead, posts further gains
Published: September 09, 2025 by: Finbold
Sentiment: Neutral
UnitedHealth Group (NYSE: UNH) shares are showing signs of life after months of punishing declines, with the stock climbing in pre-market trading on September 9.
Read More
UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH is leveraging AI to streamline insurance and care delivery, aiming to boost efficiency and improve patient outcomes.
Read More
3 Stocks Billionaire David Tepper Just Scooped Up
Published: September 08, 2025 by: 24/7 Wall Street
Sentiment: Positive
Billionaire investment legend David Tepper was quite busy in the second quarter, as he added to his stake in a number of intriguing firms, many of which seem to trade at far less than the market multiple.
Read More
Cyberattack Hangover: Senators Question UnitedHealth's Loan Playbook
Published: September 02, 2025 by: Zacks Investment Research
Sentiment: Negative
Senators question UNH over tough loan repayment demands post-cyberattack, adding to regulatory and cost pressures.
Read More
UnitedHealth: A Healthcare Giant To Hold For Years
Published: September 02, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth is a dominant, profitable healthcare leader trading at a significant discount after a 47% decline, with most risks already priced in. Despite near-term EPS pressure from rising medical costs, revenue growth remains strong and a turnaround is likely as cost headwinds subside. The stock offers a compelling 2.85% dividend yield, robust payout history, and consistent double-digit dividend growth, making it attractive for income investors.
Read More
Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Why Is UnitedHealth (UNH) Up 14.2% Since Last Earnings Report?
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Read More
Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Negative
UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.
Read More
UnitedHealth: A Generational Buying Opportunity
Published: August 27, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth's stock sell-off is overdone; the current valuation reflects temporary setbacks, not a structural decline, creating a generational buying opportunity. UNH's integrated insurance and healthcare model, market dominance, and irreplaceable role in the US system underpin long-term growth potential. Management's pricing strategy and projected EPS growth support a rebound in margins and justify a Strong Buy rating at current levels.
Read More
Justice Department Investigates UnitedHealth Group Pharmacy Business and Doctor Reimbursements
Published: August 26, 2025 by: PYMNTS
Sentiment: Negative
A Justice Department criminal investigation of UnitedHealth Group is reportedly broader than initially thought. Bloomberg reported Tuesday (Aug.
Read More
UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Berkshire's $1.57B bet on UNH sparks investor interest, but soaring costs, weak earnings and legal woes still cloud recovery hopes.
Read More
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH expands behavioral health with Optum's digital tools, partnerships and integrated care to tap rising demand.
Read More
UnitedHealth: 2026 Repricing Will Be A Game Changer
Published: August 25, 2025 by: Seeking Alpha
Sentiment: Positive
UNH's stock collapse is a rare blue-chip event, driven by temporary cost spikes and cyclical headwinds, not a broken business model. Insider and smart money buying—including Berskshire Hathaway's $1.6B stake—signals deep value and a contrarian opportunity at current depressed valuations. Optum's vertical integration and earnings power create a moat; at current prices, I believe the insurance business is essentially free.
Read More
UnitedHealth: UNH Stock To $600?
Published: August 25, 2025 by: Forbes
Sentiment: Positive
With Warren Buffett's endorsement renewing investor confidence, the debate shifts from how low UnitedHealth stock could fall to how high it might rebound. At roughly 12 times trailing adjusted earnings versus a three-year average of 25 times, a climb from around $300 to above $600 is plausible—levels the stock touched just a few months ago, before things went south.
Read More
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
Read More
UnitedHealth: Contrarians Should Have A Stomach For Volatility Until 2026
Published: August 22, 2025 by: Seeking Alpha
Sentiment: Negative
I initiate my coverage on UNH with a hold rating. Despite attractive valuation, with the P/E near 2014 levels and EV/EBITDA ~30% below sector median, I prefer to wait until the pessimism clears out. My main concern is the reinstated FY 2025 guidance at much lower EPS and the DOJ scrutiny. Overall, I don't believe the headwinds are fully priced in.
Read More
Is This Warren Buffett Stock the One That Makes You a Millionaire?
Published: August 22, 2025 by: 24/7 Wall Street
Sentiment: Positive
Key Points in This Article: Warren Buffett seeks stocks with strong fundamentals undervalued due to market fear.
Read More
UnitedHealth: One Of The Best Of Medical Services Industry
Published: August 22, 2025 by: Seeking Alpha
Sentiment: Positive
UNH stands out among peers for its strong dividend yield, consistent FCF generation, and expected double-digit dividend growth, making it my top healthcare pick. Despite recent setbacks—poor earnings, DOJ investigation, and reputational hits—I view these as temporary, presenting a long-term buying opportunity at a bargain price. Valuation models show UNH is trading at a 31% discount to fair value, with potential annualized returns between 11.7% and 18.8% over five years.
Read More
The Market Oversold UnitedHealth's Troubles
Published: August 22, 2025 by: Seeking Alpha
Sentiment: Positive
Berkshire Hathaway's $1.6B stake signals confidence in UnitedHealth, driving a sharp rally after a year of heavy declines and episodic setbacks. UNH's fundamentals remain robust: strong cash flow, scale, and attractive valuation metrics versus peers, despite recent profit pressures and cost overruns. Key catalysts include guidance stabilization, Medicare Advantage pricing, and operational improvements; most negative events appear priced in, tilting risk/reward to the upside.
Read More
UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Neutral
UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000